<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00292838</url>
  </required_header>
  <id_info>
    <org_study_id>RP#01-1929</org_study_id>
    <nct_id>NCT00292838</nct_id>
  </id_info>
  <brief_title>Relative Potency of Inhaled Corticosteroids</brief_title>
  <official_title>Relative Potency of Inhaled Corticosteroids: Validation of a Clinical Model</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Joseph's Healthcare Hamilton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Joseph's Healthcare Hamilton</source>
  <brief_summary>
    <textblock>
      To investigate the validity of a clinical model to determine the relative potency of
      different preparations of inhaled corticosteroids used for the treatment of asthma or of
      eosinophilic bronchitis without asthma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2001</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <primary_completion_date type="Actual">February 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sputum eosinophils</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exhaled nitric oxide, FEV1, FEF25-75%</measure>
  </secondary_outcome>
  <enrollment>40</enrollment>
  <condition>Asthma</condition>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fluticasone 25, 50, 100, 200 mcg</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sputum eosinophilia &gt;3%

          -  Adults age 18-70 years

          -  History of episodic wheeze, chest tightness, dyspnea or cough within the last 12
             months.

          -  FEV1 ≥ 60% predicted

          -  Steroid naive or on not more than 500 µg a day of beclomethasone or equivalent.

          -  Able to give written informed consent

        Exclusion Criteria:

          1. Recent asthma or COPD exacerbation (as judged by the clinician) due to respiratory
             infection within the last month

          2. Relevant seasonal allergen exposure within 4 weeks or within the course of the study

          3. Treatment with prednisone or antibiotics or hospitalisation within the past 6 weeks

          4. Other respiratory diseases

          5. Women who are pregnant or unwilling to use appropriate contraception during the study

          6. Unable to withhold short-acting ß-agonist treatment for 6 hours before visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederick E Hargreave, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Firestone Institute for Respiratory Health, St. Joseph's Healthcare</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2006</study_first_submitted>
  <study_first_submitted_qc>February 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2006</study_first_posted>
  <last_update_submitted>July 19, 2011</last_update_submitted>
  <last_update_submitted_qc>July 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2011</last_update_posted>
  <keyword>Eosinophilic bronchitis with asthma</keyword>
  <keyword>Eosinophilic bronchitis without asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluticasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

